Cineplex (TSX:CGX) Craters After Disappointing Q1

Cineplex (TSX:CGX) missed on the top and bottom lines as COVID-19 wrecks havoc on its business model. Is the company’s stock a buy today?

| More on:
edit Close-up Of A Piggybank With Eyeglasses And Calculator On Desk

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Arguably, one of the hardest-hit stocks by the pandemic, Cineplex (TSX:CGX) is down by approximately 71% year to date. Given the prolonged economic shutdown, Cineplex’s viability is now in question. 

Investors are anxious to see how the company is faring, and whether there’s a risk of insolvency. This is why Tuesday’s quarterly results were so important.

As with most companies, expectations were low heading into earnings. How did Cineplex perform? Let’s take a look. 

The earnings report

After the bell on Tuesday, the company reported first-quarter results ended March 31, 2020:

Metric Reported Expected
Earnings per share -$2.43 -$0.43
Revenue $282.2 million $316.44

That wasn’t pretty. Cineplex posted a big net loss and missed on both the top and bottom lines. Notably, the majority of analysts pulled estimates and only two were left standing. Given this, the big miss can be a little misleading and the earnings miss contains a pretty significant impairment charge.

There is however, no way to sugarcoat the last quarter. Year over year (YOY), revenue dropped by 22.4% and theatre attendance cratered. Attendance came in at 10.7 million, down from 15 million in the same quarter last year. 

The lone bright spot came from the company’s digital commerce segment. The Cineplex Store saw revenue increase by 37% and quarterly active users jumped by 43%. Overall however, it was a quarter to forget. 

The industry is one of the hardest hit, and most cinemas won’t begin to see a meaningful increase in attendance until the last phases of reopening. Large media companies are delaying tent pole films and even if they were to reopen, cinemas have little in terms of new content to offer. 

The year ahead

The deal with Cineworld is all but dead. The U.K. theatre company terminated its agreement to buy the company, citing a breach of terms and conditions. Cineplex has since disputed these claims and intends to sue for damages. 

At issue is the company’s debt covenants. As part of the deal, Cineplex must maintain the prescribed financial covenants and not take on any additional debt. As of the end of the quarter, it was in compliance but said a potential breach is likely over the next couple of quarters. 

That said, now that the deal is over, Cineplex will now be on its own. Unfortunately, this will be no easy task. The company closed all of its theatres and location-based entertainment venues and is effectively on life support.

It is in the process of seeking additional financing and entered into an amendment agreement with current lenders. As part of the amendment, the company will have access to an additional $250 in financing, which will help pay down current obligations. 

Is Cineplex a buy today?

The jury is still out on this company. Bottom line, this is a play on a rebound in the economy. If all goes well, Cineplex can rebound in a big way with big tent pole films on deck. 

However, as we’ve seen in recent weeks, the economic re-opening has been anything but smooth. Movie studios are consistently pushing back films, and most provinces are not fully reopen. Similarly, Cineplex will not be operating at full capacity for a while, as they will need to implement social distancing measures. 

Finally, any considerable setback has the potential to send the Cineplex into bankruptcy. This is a real possibility, and one that shareholders must take into account.  According to the company, “…material uncertainties lend significant doubt about the Company’s ability to continue as a going concern.”

At this point, the company is only appropriate for those high-risk investors.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Mat Litalien owns shares of CINEPLEX INC.

More on Coronavirus

little girl in pilot costume playing and dreaming of flying over the sky
Coronavirus

Air Canada Stock: How High Could it go?

AC stock is up 29% in the last six months alone, so should we expect more great things? Or is…

Read more »

eat food
Coronavirus

Goodfood Stock Doubles Within Days: Time to Buy?

Goodfood (TSX:FOOD) stock has surged 125% in the last few weeks, so what happened, and should investors hop back on…

Read more »

stock data
Tech Stocks

If I Could Only Buy 1 Stock Before 2023, This Would Be It

This stock is the one company that really doesn't deserve its ultra-low share price, so I'll definitely pick it up…

Read more »

Aircraft Mechanic checking jet engine of the airplane
Coronavirus

Air Canada Stock Fell 5% in November: Is it a Buy Today?

Air Canada (TSX:AC) stock saw remarkable improvements during its last quarter but still dropped 5% with more recession hints. So,…

Read more »

Airport and plane
Coronavirus

Is Air Canada Stock a Buy Today?

Airlines are on the rebound. Does Air Canada stock deserve to be on your buy list?

Read more »

A patient takes medicine out of a daily pill box.
Coronavirus

Retirees: 2 Healthcare Stocks That Could Help Set You up for Life

Healthcare stocks offer an incredible opportunity for growth for those investors who look to the right stocks, such as these…

Read more »

sad concerned deep in thought
Coronavirus

Here’s Why I Just Bought WELL Health Stock

WELL Health stock (TSX:WELL) may be a healthcare stock and a tech stock, but don't let that keep you from…

Read more »

healthcare pharma
Coronavirus

WELL Stock: The Safe Stock Investors Can’t Afford to Ignore

WELL stock (TSX:WELL) fell 68% from peak to trough, and yet there's no good reason as to why. So now…

Read more »